Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,279.20
(
0.61%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.93
(
-0.72%
)
Bitcoin
74,110.11
(
0.23%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

stockdak

Send PM Follow Ignore
Followers 1
Posts 80
Boards Moderated 0
Alias Born 06/05/2007

stockdak

Re: DewDiligence post# 54609

Friday, 11/09/2007 7:32:50 PM

Friday, November 09, 2007 7:32:50 PM

Post# of 257253
MNTA: A little knowledge is a dangerous thing...

Yes I had M118 and M-Enoxaparin confused.

Still if M-Enoxaparin is a more homogenous version of Lovenox and Lovenox has about 1% of patients with HIT response (compared to 5% for UFH) the hope is that M-Enoxaparin will be more like Arixtra which shows no HIT compared to Lovenox.

DAK
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now